Skip to main content
Toggle navigation
Search
Home
Back
Favorite
0
Like
Facebook
Print
Session III: Cancer of the Biliary Tract
O-1: Outcomes by primary tumour location in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the Phase 3 TOPAZ-1 study
Wednesday, June 29, 2022
17:15 – 17:27
Location: Auditorium A; Level 0
Abstract Presenter(s)
AH
Aiwu Ruth He
